{
    "Variants Include": [
        {
            "Gene": "LRRK2",
            "variants": [
                {
                    "HGVS": "NM_198578.4:c.4321C>G",
                    "cDNA Change": {
                        "transcript": "NM_198578.4",
                        "ref": "C",
                        "alt": "G",
                        "position": "4321"
                    },
                    "Protein Change": {
                        "ref": "R",
                        "alt": "G",
                        "position": "1441"
                    },
                    "Description in input context": "R1441G"
                },
                {
                    "HGVS": "NM_198578.4:c.5096A>G",
                    "cDNA Change": {
                        "transcript": "NM_198578.4",
                        "ref": "A",
                        "alt": "G",
                        "position": "5096"
                    },
                    "Protein Change": {
                        "ref": "Y",
                        "alt": "C",
                        "position": "1699"
                    },
                    "Description in input context": "Y1699C"
                },
                {
                    "HGVS": "NM_198578.4:c.6055G>A",
                    "cDNA Change": {
                        "transcript": "NM_198578.4",
                        "ref": "G",
                        "alt": "A",
                        "position": "6055"
                    },
                    "Protein Change": {
                        "ref": "G",
                        "alt": "S",
                        "position": "2019"
                    },
                    "Description in input context": "G2019S"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson's Disease",
        "MONDO": "MONDO:0005180"
    },
    "Experiment Method": [
        {
            "Assay Method": "Western Blot",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "HEK-293T",
                "Description": "FLAG-LRRK2 WT or mutant plasmids were transfected into HEK-293T cells for analysis."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_198578.4:c.4321C>G",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "Reduced phosphorylation at S935 and impaired 14-3-3 binding for R1441G."
                },
                {
                    "Variant": "NM_198578.4:c.5096A>G",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "Reduced phosphorylation at S935 and impaired 14-3-3 binding for Y1699C."
                },
                {
                    "Variant": "NM_198578.4:c.6055G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "Modest reduction in phosphorylation at S935 and slight impairment in 14-3-3 binding for G2019S."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Data are presented as mean value (6 SEM) from three independent experiments."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "Not described in the literature."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type LRRK2 was used as a positive control for phosphorylation and binding studies."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "S935A mutant was used as a negative control for phosphorylation and 14-3-3 binding."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "3"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "One-way ANOVA was used for statistical analysis."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Phosphorylation levels comparable to wild-type LRRK2.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Significant reduction in phosphorylation levels compared to wild-type LRRK2.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Co-Immunoprecipitation (Co-IP)",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "HEK-293T",
                "Description": "HEK-293T cells were transfected with FLAG-LRRK2 and Myc-14-3-3 plasmids for Co-IP studies."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_198578.4:c.4321C>G",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "Reduced 14-3-3 binding for R1441G."
                },
                {
                    "Variant": "NM_198578.4:c.5096A>G",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "Reduced 14-3-3 binding for Y1699C."
                },
                {
                    "Variant": "NM_198578.4:c.6055G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "Slight reduction in 14-3-3 binding for G2019S."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Data are presented as mean value (6 SEM) from three independent experiments."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "Not described in the literature."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type LRRK2 was used as a positive control for 14-3-3 binding."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "S935A mutant was used as a negative control for 14-3-3 binding."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "3"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "One-way ANOVA was used for statistical analysis."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Binding levels comparable to wild-type LRRK2.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Significant reduction in binding levels compared to wild-type LRRK2.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "GST Pull-Down Assay",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "HEK-293T",
                "Description": "GST-14-3-3 isoforms were incubated with FLAG-LRRK2 transfected HEK-293T cell lysates."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_198578.4:c.4321C>G",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "Markedly reduced 14-3-3 binding for R1441G."
                },
                {
                    "Variant": "NM_198578.4:c.5096A>G",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "Markedly reduced 14-3-3 binding for Y1699C."
                },
                {
                    "Variant": "NM_198578.4:c.6055G>A",
                    "Conclusion": "Normal",
                    "Molecular Effect": "No Effect",
                    "Result Description": "Little effect on 14-3-3 binding for G2019S."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Data are presented as mean value (6 SEM) from three independent experiments."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "Not described in the literature."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type LRRK2 was used as a positive control for 14-3-3 binding."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "S935A mutant was used as a negative control for 14-3-3 binding."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "3"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "One-way ANOVA was used for statistical analysis."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Binding levels comparable to wild-type LRRK2.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Significant reduction in binding levels compared to wild-type LRRK2.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "PKA Kinase Assay",
            "Material used": {
                "Material Source": "Recombinant Protein",
                "Material Name": "GST-LRRK2 fragment (800-1000aa)",
                "Description": "GST-LRRK2 fragment was incubated with PKA catalytic subunit for kinase activity analysis."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_198578.4:c.4321C>G",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Not specifically tested for R1441G in this assay."
                },
                {
                    "Variant": "NM_198578.4:c.5096A>G",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Not specifically tested for Y1699C in this assay."
                },
                {
                    "Variant": "NM_198578.4:c.6055G>A",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Not specifically tested for G2019S in this assay."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "Not described in the literature."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "Not described in the literature."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "PKA phosphorylation of GSK was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "H89 inhibitor was used to block PKA activity as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "No",
                "Counts": "0"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "One-way ANOVA was used for statistical analysis."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Phosphorylation levels increased with PKA activity.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "No significant increase in phosphorylation levels with PKA activity.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}